Search Results - "Stienstra, Y"

eHealth in TB clinical management by Margineanu, I., Louka, C., Akkerman, O., Stienstra, Y., Alffenaar, J-W.

“…BACKGROUND: The constant expansion of internet and mobile technologies has created new opportunities in the field of eHealth, or the digital delivery of…”
Get full text

TB therapeutic drug monitoring - analysis of opportunities in Romania and Ukraine by Margineanu, I., Butnaru, T., Gafar, F., Baiceanu, D., Dragomir, R., Semianiv, I., Mihaltan, F., Munteanu, I., Mahler, B., Todoriko, L., Margineanu, S., Akkerman, O., Stienstra, Y., Alffenaar, J-W. C.

“…INTRODUCTION: Therapeutic drug monitoring (TDM) could improve TB treatment outcomes by avoiding drug toxicity or underdosing. In this study, we describe the…”
Get full text

Louse-borne relapsing fever (Borrelia recurrentis) in asylum seekers from Eritrea, the Netherlands, July 2015 by Wilting, K R, Stienstra, Y, Sinha, B, Braks, M, Cornish, D, Grundmann, H

“…Two patients from Eritrea, recently arrived in the Netherlands, presented with fever and were investigated for malaria. Bloodfilms showed spirochetes but no…”
Get full text

Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy by Klis, S., Kingma, R. A., Tuah, W., Werf, T. S., Stienstra, Y.

“…Objectives Buruli ulcer (BU) is a tropical skin disease caused by infection with Mycobacterium ulcerans, which is currently treated with 8 weeks of…”
Get full text

Compliance with antimicrobial therapy for buruli ulcer by Klis, S, Kingma, R, Tuah, W, Stienstra, Y, van der Werf, T S

Get full text

Management of BU–HIV co‐infection by O'Brien, D. P., Ford, N., Vitoria, M., Christinet, V., Comte, E., Calmy, A., Stienstra, Y., Eholie, S., Asiedu, K.

“…Background Buruli Ulcer (BU)–HIV co‐infection is an important emerging management challenge for BU disease. Limited by paucity of scientific studies, guidance…”
Get full text

Trimethoprim/sulfamethoxazole susceptibility of Mycobacterium tuberculosis by Alsaad, N, van der Laan, T, van Altena, R, Wilting, K.R, van der Werf, T.S, Stienstra, Y, van Soolingen, D, Alffenaar, J.W.C

Get full text

Risk Factors for Buruli Ulcer Disease (Mycobacterium ulcerans Infection): Results from a Case-Control Study in Ghana by Raghunathan, Pratima L., Whitney, Ellen A.S., Asamoa, Kwame, Stienstra, Ymkje, Taylor, Thomas H., Amofah, George K., Ofori-Adjei, David, Dobos, Karen, Guarner, Jeannette, Martin, Stacey, Pathak, Sonal, Klutse, Erasmus, Etuaful, Samuel, van der Graaf, Winette T.A., van der Werf, Tjip S., King, C.H., Tappero, Jordan W., Ashford, David A.

“…Background Morbidity due to Buruli ulcer disease (BUD), a cutaneous infection caused by Mycobacterium ulcerans, has been increasingly recognized in rural West…”
Get full text

A cluster of tularaemia after contact with a dead hare in the Netherlands by van de Wetering, D, Oliveira dos Santos, C, Wagelaar, M, de Kleuver, M, Koene, M G J, Roest, H I J, Sinha, B, Tomaso, H, Bierman, W F W, Stienstra, Y

“…Tularemia is thought to be rare in the Netherlands. Here we describe a cluster of two patients who contracted tularaemia after field dressing of a hare found…”
Get full text

Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism by Stienstra, Y, van der Werf, T S, Oosterom, E, Nolte, I M, van der Graaf, W T A, Etuaful, S, Raghunathan, P L, Whitney, E A S, Ampadu, E O, Asamoa, K, Klutse, E Y, te Meerman, G J, Tappero, J W, Ashford, D A, van der Steege, G

“…Similar to other mycobacterial diseases, susceptibility to Buruli ulcer (Mycobacterium ulcerans infection) may be determined by host genetic factors. We…”
Get full text

Decreased capillary permeability and capillary density in patients with systemic sclerosis using large-window sodium fluorescein videodensitometry of the ankle by Hettema, M. E., Zhang, D., Stienstra, Y., Oomen, P. N. H., Smit, A. J., Kallenberg, C. G. M., Bootsma, H.

“…Objective. Local capillary permeability in patients with SSc has been reported increased when assessed by nail-fold capillaroscopy. We measured capillary…”
Get full text

Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors by Stienstra, Y., Van Der Graaf, W. T. A., Te Meerman, G. J., The, T. H., De Leij, L. F., Van Der Werf, T. S.

“…Mycobacterium ulcerans disease, also known as Buruli ulcer (BU), is a disease of subcutaneous fat tissue. BU is prevalent in riverine and swamp areas of the…”
Get full text

Buruli ulcer: differences in treatment outcome between two centres in Ghana by Teelken, M.A., Stienstra, Y., Ellen, D.E., Quarshie, E., Klutse, E., van der Graaf, W.T.A., van der Werf, Tjip S.

“…Objectives: Assess treatment effects by following up patients treated for Buruli ulcer in two hospitals with different treatment aspects, including widely…”
Get full text

Morbidity in Hospitalized Patients Receiving Human Albumin: A Meta-Analysis of Randomized, Controlled Trials by Regtien, J G, Stienstra, Y, Ligtenberg, J J. M, van der Werf, T S, Tulleken, J E, Zijlstra, J G

Get full text

Mixing Up All the Results by Regtien, J G, Stienstra, Y, Ligtenberg, J J, van der Werf, T S, Tulleken, J E, Zijlstra, J G

Get full text

4.10-P18Chronic infections in migrants by Carballo, M, Friedland, J, Nellums, L, Stienstra, Y

Get full text

4.10-P18; Chronic infections in migrants by Carballo, M, Friedland, J, Nellums, L, Stienstra, Y

Get full text

Emerging infections—an increasingly important topic: review by the Emerging Infections Task Force by Petersen, E., Petrosillo, N., Koopmans, M., Beeching, N., Di Caro, A., Gkrania-Klotsas, E., Kantele, A., Kohlmann, R., Koopmans, M., Lim, P.-L., Markotic, A., López-Vélez, R., Poirel, L., Rossen, J.W.A., Stienstra, Y., Storgaard, M.

“…This paper review trends in emerging infections and the need for increased clinical and laboratory surveillance. Factors that contributed to the emergence of…”
Get full text

The public health control of scabies: priorities for research and action by Stienstra, Ymkje, Beeres, Dorien T, Phillips, Richard, Vonk, Machiel, Ravensbergen, Sofanne J

Get full text

Paradoxical Responses After Start of Antimicrobial Treatment in Mycobacterium ulcerans Infection by Nienhuis, Willemien A., Stienstra, Ymkje, Abass, K. Mohammed, Tuah, Wilson, Thompson, William A., Awuah, Peter C., Awuah-Boateng, Nana Yaa, Adjei, Ohene, Bretzel, Gisela, Schouten, Jan P., van der Werf, Tjip S.

“…Background. Antimicrobial killing in mycobacterial infections may be accompanied by (transient) clinical deterioration, known as paradoxical reaction. To…”
Get full text